The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Mitigating Preeclampsia Risk May Reduce Preterm Birth, Cesarean Delivery

Mitigating Preeclampsia Risk May Reduce Preterm Birth, Cesarean Delivery

December 14, 2020 • By Mary Beth Nierengarten

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Mitigating Preeclampsia

“Of the three pregnancy complications we assessed, mitigating the risk of preeclampsia will do the most to reduce the risk of preterm birth and cesarean delivery in women with RA, SLE and psoriasis,” says Dr. Bandoli. “However, we would not expect it to have as much impact on those outcomes in women with IBD.”

You Might Also Like
  • Lupus Flares Pose Greatest Risk for Adverse Pregnancy Outcomes in Women with SLE
  • A More Complicated Pregnancy: Inflammatory Arthritis Increases the Risk for Adverse Outcomes
  • Juvenile-Onset Arthritis Bodes Worse Pregnancy Outcomes
Explore This Issue
December 2020
Also By This Author
  • The ACR Is Exploring a Rheumatology-Specific APM

For women with IBD, the study findings didn’t provide information on any pregnancy complications that may explain the excess risk of adverse pregnancy outcomes, according to Dr. Bandoli. “[This] suggests that either the disease directly affects the risk, instead of through pregnancy complications, or it’s operating through mediated pathways that we did not consider” she says.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The data also do not suggest that interventions targeted at pregnancy infection or gestational diabetes will have much of an impact on reducing these select adverse birth outcomes in women with auto­immune disease, Dr. Bandoli says.


Mary Beth Nierengarten is a freelance medical journalist based in Minneapolis.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Reference

  1. Bandoli G, Singh N, Strouse J, et al. Mediation of adverse pregnancy outcomes in autoimmune conditions by pregnancy complications: A mediation analysis of autoimmune conditions and adverse pregnancy outcomes. Arthritis Care Res (Hoboken). 2020 Feb;72(2):256–264.

Pages: 1 2 | Single Page

Filed Under: Conditions, Research Reviews Tagged With: preeclampsia, pregnancyIssue: December 2020

You Might Also Like:
  • Lupus Flares Pose Greatest Risk for Adverse Pregnancy Outcomes in Women with SLE
  • A More Complicated Pregnancy: Inflammatory Arthritis Increases the Risk for Adverse Outcomes
  • Juvenile-Onset Arthritis Bodes Worse Pregnancy Outcomes
  • Antiphospholipid Antibody Syndrome Puts Pregnant Women at High Risk of Preeclampsia

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)